Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1974 2
1975 1
1976 1
1977 1
1978 2
1981 2
1982 1
1984 1
1985 1
1986 4
1987 1
1988 6
1989 3
1990 2
1991 5
1992 3
1993 6
1994 3
1995 5
1996 3
1997 1
1998 2
2000 2
2001 3
2002 2
2004 5
2005 2
2006 2
2007 1
2008 1
2009 1
2010 2
2011 5
2012 4
2013 4
2015 2
2016 1
2017 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, Vass K, Clifford DB, Hauser S, Major EO, O'Connor PW, Weiner HL, Clanet M, Gold R, Hirsch HH, Radü EW, Sørensen PS, King J. Kappos L, et al. Among authors: vass k. Lancet Neurol. 2011 Aug;10(8):745-58. doi: 10.1016/S1474-4422(11)70149-1. Lancet Neurol. 2011. PMID: 21777829 Free article. Review.
The role of Raf kinases in malignant transformation.
Kolch W, Kotwaliwale A, Vass K, Janosch P. Kolch W, et al. Among authors: vass k. Expert Rev Mol Med. 2002 Apr 25;4(8):1-18. doi: 10.1017/S1462399402004386. Expert Rev Mol Med. 2002. PMID: 14987392 Review.
Escalating immunotherapy of multiple sclerosis--new aspects and practical application.
Rieckmann P, Toyka KV, Bassetti C, Beer K, Beer S, Buettner U, Chofflon M, Götschi-Fuchs M, Hess K, Kappos L, Kesselring J, Goebels N, Ludin HP, Mattle H, Schluep M, Vaney C, Baumhackl U, Berger T, Deisenhammer F, Fazekas F, Freimüller M, Kollegger H, Kristoferitsch W, Lassmann H, Markut H, Strasser-Fuchs S, Vass K, Altenkirch H, Bamborschke S, Baum K, Benecke R, Brück W, Dommasch D, Elias WG, Gass A, Gehlen W, Haas J, Haferkamp G, Hanefeld F, Hartung HP, Heesen C, Heidenreich F, Heitmann R, Hemmer B, Hense T, Hohlfeld R, Janzen RW, Japp G, Jung S, Jügelt E, Koehler J, Kölmel W, König N, Lowitzsch K, Manegold U, Melms A, Mertin J, Oschmann P, Petereit HF, Pette M, Pöhlau D, Pohl D, Poser S, Sailer M, Schmidt S, Schock G, Schulz M, Schwarz S, Seidel D, Sommer N, Stangel M, Stark E, Steinbrecher A, Tumani H, Voltz R, Weber F, Weinrich W, Weissert R, Wiendl H, Wiethölter H, Wildemann U, Zettl UK, Zipp F, Zschenderlein R, Izquierdo G, Kirjazovas A, Packauskas L, Miller D, Koncan Vracko B, Millers A, Orologas A, Panellus M, Sindic CJ, Bratic M, Svraka A, Vella NR, Stelmasiak Z, Selmaj K, Bartosik-Psujik H, Mitosek-Szewczyk K, Belniak E, Mochecka A, Bayas A, Chan A, Flachenecker P, Gold R, Kallmann B, Leussink V, Mäurer M, Ruprecht K, Stoll G, Weilbach FX; Multiple Sclerosis Therapy Consensus Group. Rieckmann P, et al. Among authors: vass k. J Neurol. 2004 Nov;251(11):1329-39. doi: 10.1007/s00415-004-0537-6. J Neurol. 2004. PMID: 15592728 Review.
Fingolimod in the treatment algorithm of relapsing remitting multiple sclerosis: a statement of the Central and East European (CEE) MS Expert Group.
Fazekas F, Berger T, Fabjan TH, Ledinek AH, Jakab G, Komoly S, Kraus J, Kurča E, Kyriakides T, Lisý L, Milanov I, Panayiotou P, Jazbec SS, Taláb R, Traykov L, Turčáni P, Vass K, Vella N, Havrdová E. Fazekas F, et al. Among authors: vass k. Wien Med Wochenschr. 2012 Aug;162(15-16):354-66. doi: 10.1007/s10354-012-0123-y. Epub 2012 Aug 16. Wien Med Wochenschr. 2012. PMID: 22895849 Free PMC article. Review.
Unilateral Creutzfeldt-Jakob disease.
Yamanouchi H, Budka H, Vass K Sr. Yamanouchi H, et al. Among authors: vass k sr. Neurology. 1986 Nov;36(11):1517-20. doi: 10.1212/wnl.36.11.1517. Neurology. 1986. PMID: 3531919
[Current therapy of multiple sclerosis].
Vass K, Schmied M. Vass K, et al. Wien Med Wochenschr. 1996;146(19-20):514-9. Wien Med Wochenschr. 1996. PMID: 9082651 Review. German.
Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.
Salhofer-Polanyi S, Windt J, Sumper H, Grill H, Essmeister M, Diermayr G, Zebenholzer K, Leutmezer F, Zulehner G, Vass K, Asenbaum-Nan S. Salhofer-Polanyi S, et al. Among authors: vass k. NeuroRehabilitation. 2013;33(2):285-92. doi: 10.3233/NRE-130956. NeuroRehabilitation. 2013. PMID: 23949063 Clinical Trial.
Natalizumab therapy for highly active pediatric multiple sclerosis.
Kornek B, Aboul-Enein F, Rostasy K, Milos RI, Steiner I, Penzien J, Hellwig K, Pitarokoili K, Storm van's Gravesande K, Karenfort M, Blaschek A, Meyer A, Seidl R, Debelic D, Vass K, Prayer D, Kristoferitsch W, Bayas A. Kornek B, et al. Among authors: vass k. JAMA Neurol. 2013 Apr;70(4):469-75. doi: 10.1001/jamaneurol.2013.923. JAMA Neurol. 2013. PMID: 23420110
95 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page